The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers
(Q82877586)
scientific article published on 01 March 2006
scientific article published on 01 March 2006
Language:
Current Data About
The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers
other details
| description | scientific article published on 01 March 2006 |
External Links
| (P356) |
10.1158/1535-7163.MCT-05-0245
|
| (P698) |
16546983
|